148 related articles for article (PubMed ID: 36805391)
1. Endocannabinoids are potential inhibitors of glioblastoma multiforme proliferation.
Duzan A; Reinken D; McGomery TL; Ferencz NM; Plummer JM; Basti MM
J Integr Med; 2023 Mar; 21(2):120-129. PubMed ID: 36805391
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoids in the treatment of glioblastoma.
Buchalska B; Kamińska K; Owe-Larsson M; Cudnoch-Jędrzejewska A
Pharmacol Rep; 2024 Apr; 76(2):223-234. PubMed ID: 38457018
[TBL] [Abstract][Full Text] [Related]
3. The effects of cannabinoids on glioblastoma growth: A systematic review with meta-analysis of animal model studies.
Luís Â; Marcelino H; Rosa C; Domingues F; Pereira L; Cascalheira JF
Eur J Pharmacol; 2020 Jun; 876():173055. PubMed ID: 32145324
[TBL] [Abstract][Full Text] [Related]
4. The antitumor action of endocannabinoids in the tumor microenvironment of glioblastoma.
Tang Y; Wang M; Yu J; Lv G; Wang Y; Yu B
Front Pharmacol; 2024; 15():1395156. PubMed ID: 38720772
[TBL] [Abstract][Full Text] [Related]
5. Pyr3 Induces Apoptosis and Inhibits Migration in Human Glioblastoma Cells.
Chang HH; Cheng YC; Tsai WC; Tsao MJ; Chen Y
Cell Physiol Biochem; 2018; 48(4):1694-1702. PubMed ID: 30078005
[TBL] [Abstract][Full Text] [Related]
6. Inhibiting receptor tyrosine kinase AXL with small molecule inhibitor BMS-777607 reduces glioblastoma growth, migration, and invasion in vitro and in vivo.
Onken J; Torka R; Korsing S; Radke J; Krementeskaia I; Nieminen M; Bai X; Ullrich A; Heppner F; Vajkoczy P
Oncotarget; 2016 Mar; 7(9):9876-89. PubMed ID: 26848524
[TBL] [Abstract][Full Text] [Related]
7. IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastoma.
Guo G; Sun Y; Hong R; Xiong J; Lu Y; Liu Y; Lu J; Zhang Z; Guo C; Nan Y; Huang Q
Clin Transl Oncol; 2020 Aug; 22(8):1252-1262. PubMed ID: 31865606
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of tyrosine kinase inhibitor combinations for glioblastoma therapy.
Joshi AD; Loilome W; Siu IM; Tyler B; Gallia GL; Riggins GJ
PLoS One; 2012; 7(10):e44372. PubMed ID: 23056179
[TBL] [Abstract][Full Text] [Related]
9. Current status and future therapeutic perspectives of glioblastoma multiforme (GBM) therapy: A review.
Anjum K; Shagufta BI; Abbas SQ; Patel S; Khan I; Shah SAA; Akhter N; Hassan SSU
Biomed Pharmacother; 2017 Aug; 92():681-689. PubMed ID: 28582760
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of cannabinoids against glioblastoma multiforme: A systematic review.
Kyriakou I; Yarandi N; Polycarpou E
Phytomedicine; 2021 Jul; 88():153533. PubMed ID: 33812759
[TBL] [Abstract][Full Text] [Related]
11. Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents.
Nabissi M; Morelli MB; Santoni M; Santoni G
Carcinogenesis; 2013 Jan; 34(1):48-57. PubMed ID: 23079154
[TBL] [Abstract][Full Text] [Related]
12. Study on Therapeutic Action and Mechanism of TMZ Combined with RITA Against Glioblastoma.
Wu Q; Cao Z; Xiao W; Zhu L; Xie Q; Li L; Zhang B; Zhao W
Cell Physiol Biochem; 2018; 51(6):2536-2546. PubMed ID: 30562758
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol as an antitumor agent for glioblastoma multiforme: Targeting resistance and promoting apoptotic cell deaths.
Karkon-Shayan S; Aliashrafzadeh H; Dianat-Moghadam H; Rastegar-Pouyani N; Majidi M; Zarei M; Moradi-Vastegani S; Bahramvand Y; Babaniamansour S; Jafarzadeh E
Acta Histochem; 2023 Aug; 125(6):152058. PubMed ID: 37336070
[TBL] [Abstract][Full Text] [Related]
14. Deregulated signaling pathways in glioblastoma multiforme: molecular mechanisms and therapeutic targets.
Mao H; Lebrun DG; Yang J; Zhu VF; Li M
Cancer Invest; 2012 Jan; 30(1):48-56. PubMed ID: 22236189
[TBL] [Abstract][Full Text] [Related]
15. Targeting the Endocannabinoid System Present in the Glioblastoma Tumour Microenvironment as a Potential Anti-Cancer Strategy.
Dasram MH; Naidoo P; Walker RB; Khamanga SM
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338649
[TBL] [Abstract][Full Text] [Related]
16. Sphingolipid signaling pathways as potential therapeutic targets in gliomas.
Van Brocklyn JR
Mini Rev Med Chem; 2007 Oct; 7(10):984-90. PubMed ID: 17979800
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators.
Brown I; Cascio MG; Rotondo D; Pertwee RG; Heys SD; Wahle KW
Prog Lipid Res; 2013 Jan; 52(1):80-109. PubMed ID: 23103355
[TBL] [Abstract][Full Text] [Related]
18. Neural precursor cells induce cell death of high-grade astrocytomas through stimulation of TRPV1.
Stock K; Kumar J; Synowitz M; Petrosino S; Imperatore R; Smith ES; Wend P; Purfürst B; Nuber UA; Gurok U; Matyash V; Wälzlein JH; Chirasani SR; Dittmar G; Cravatt BF; Momma S; Lewin GR; Ligresti A; De Petrocellis L; Cristino L; Di Marzo V; Kettenmann H; Glass R
Nat Med; 2012 Aug; 18(8):1232-8. PubMed ID: 22820645
[TBL] [Abstract][Full Text] [Related]
19. 17AEP-GA, an HSP90 antagonist, is a potent inhibitor of glioblastoma cell proliferation, survival, migration and invasion.
Miekus K; Kijowski J; Sekuła M; Majka M
Oncol Rep; 2012 Nov; 28(5):1903-9. PubMed ID: 22941268
[TBL] [Abstract][Full Text] [Related]
20. Glycogen synthase kinase-3 inhibition in glioblastoma multiforme cells induces apoptosis, cell cycle arrest and changing biomolecular structure.
Acikgoz E; Güler G; Camlar M; Oktem G; Aktug H
Spectrochim Acta A Mol Biomol Spectrosc; 2019 Feb; 209():150-164. PubMed ID: 30388586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
